Guggenheim Capital LLC lifted its stake in Cardinal Health Inc (NYSE:CAH) by 36.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,195,410 shares of the company’s stock after acquiring an additional 316,772 shares during the period. Guggenheim Capital LLC owned 0.38% of Cardinal Health worth $73,242,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of CAH. Steward Partners Investment Advisory LLC bought a new position in Cardinal Health in the 3rd quarter worth approximately $102,000. Ffcm LLC bought a new position in Cardinal Health in the 4th quarter worth approximately $105,000. JNBA Financial Advisors increased its position in Cardinal Health by 615.4% in the 4th quarter. JNBA Financial Advisors now owns 1,860 shares of the company’s stock worth $114,000 after buying an additional 1,600 shares during the period. Cerebellum GP LLC bought a new position in Cardinal Health in the 4th quarter worth approximately $129,000. Finally, James Hambro & Partners bought a new position in Cardinal Health in the 4th quarter worth approximately $138,000. 90.04% of the stock is currently owned by institutional investors and hedge funds.
In other Cardinal Health news, CEO Jon L. Giacomin sold 7,995 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $68.78, for a total value of $549,896.10. Following the completion of the sale, the chief executive officer now directly owns 63,043 shares in the company, valued at $4,336,097.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Michael C. Kaufmann sold 18,586 shares of the stock in a transaction dated Monday, January 22nd. The stock was sold at an average price of $73.90, for a total value of $1,373,505.40. Following the completion of the sale, the chief executive officer now owns 211,849 shares of the company’s stock, valued at $15,655,641.10. The disclosure for this sale can be found here. Insiders sold 55,113 shares of company stock valued at $3,815,073 over the last 90 days. Corporate insiders own 0.97% of the company’s stock.
Cardinal Health Inc (NYSE:CAH) opened at $71.16 on Monday. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.57 and a current ratio of 1.09. Cardinal Health Inc has a one year low of $54.66 and a one year high of $84.88. The stock has a market capitalization of $22,394.54, a price-to-earnings ratio of 12.38, a PEG ratio of 1.60 and a beta of 0.95.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, February 8th. The company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.17. The business had revenue of $35.19 billion during the quarter, compared to the consensus estimate of $34.63 billion. Cardinal Health had a return on equity of 24.81% and a net margin of 1.37%. The firm’s revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.34 earnings per share. analysts forecast that Cardinal Health Inc will post 5.42 EPS for the current fiscal year.
Cardinal Health announced that its Board of Directors has initiated a stock repurchase program on Thursday, February 8th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Sunday, April 15th. Investors of record on Monday, April 2nd will be issued a $0.4624 dividend. The ex-dividend date is Thursday, March 29th. This represents a $1.85 dividend on an annualized basis and a yield of 2.60%. Cardinal Health’s dividend payout ratio is presently 32.17%.
ILLEGAL ACTIVITY NOTICE: “Cardinal Health Inc (CAH) Position Lifted by Guggenheim Capital LLC” was reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2018/03/12/cardinal-health-inc-cah-position-lifted-by-guggenheim-capital-llc.html.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.